318 related articles for article (PubMed ID: 30471183)
1. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
2. High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study.
Debeij J; van Zaane B; Dekkers OM; Doggen CJ; Smit JW; van Zanten AP; Brandjes DP; Büller HR; Gerdes VE; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2014 Jun; 12(6):839-46. PubMed ID: 24679097
[TBL] [Abstract][Full Text] [Related]
3. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
[TBL] [Abstract][Full Text] [Related]
5. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.
Rauch A; Labreuche J; Lassalle F; Goutay J; Caplan M; Charbonnier L; Rohn A; Jeanpierre E; Dupont A; Duhamel A; Faure K; Lambert M; Kipnis E; Garrigue D; Lenting PJ; Poissy J; Susen S
J Thromb Haemost; 2020 Nov; 18(11):2942-2953. PubMed ID: 32881304
[TBL] [Abstract][Full Text] [Related]
6. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study.
Bugnicourt JM; Roussel B; Tramier B; Lamy C; Godefroy O
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):699-701. PubMed ID: 17189302
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study.
Timp JF; Lijfering WM; Flinterman LE; van Hylckama Vlieg A; le Cessie S; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2015 Oct; 13(10):1823-32. PubMed ID: 26270389
[TBL] [Abstract][Full Text] [Related]
8. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
Biguzzi E; Siboni SM; le Cessie S; Baronciani L; Rosendaal FR; van Hylckama Vlieg A; Peyvandi F
J Thromb Haemost; 2021 Jan; 19(1):96-106. PubMed ID: 32998182
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
[TBL] [Abstract][Full Text] [Related]
10. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.
Bittar LF; Mazetto Bde M; Orsi FL; Collela MP; De Paula EV; Annichino-Bizzacchi JM
Thromb Res; 2015 Mar; 135(3):497-501. PubMed ID: 25575413
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study.
Yap ES; Timp JF; Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2015 Oct; 13(10):1833-42. PubMed ID: 26264493
[TBL] [Abstract][Full Text] [Related]
12. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
13. Levels of prolactin in relation to coagulation factors and risk of venous thrombosis. Results of a large population-based case-control study (MEGA-study).
Stuijver DJ; Debeij J; van Zaane B; Dekkers OM; Smit JW; Büller HR; Rosendaal FR; Gerdes VE; Cannegieter SC
Thromb Haemost; 2012 Sep; 108(3):499-507. PubMed ID: 22782187
[TBL] [Abstract][Full Text] [Related]
14. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
Samai A; Monlezun D; Shaban A; George A; Dowell L; Kruse-Jarres R; Schluter L; El Khoury R; Martin-Schild S
Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor.
Sugita C; Yamashita A; Matsuura Y; Iwakiri T; Okuyama N; Matsuda S; Matsumoto T; Inoue O; Harada A; Kitazawa T; Hattori K; Shima M; Asada Y
Thromb Haemost; 2013 Jul; 110(1):62-75. PubMed ID: 23636277
[TBL] [Abstract][Full Text] [Related]
17. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
19. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
[TBL] [Abstract][Full Text] [Related]
20. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
